What should I know about sodium stibogluconate before receiving it?

Sodium stibogluconate is not approved by the U.S. Food and Drug Administration (FDA), but is considered an Investigational New Drug for leishmaniasis. Before you begin treatment, tell your doctor about any medical conditions you have, especially if you have a weakened immune system or kidney disorders. People with weakened immune systems who receive sodium stibogluconate tend to relapse or not respond well to treatment, and those with kidney disorders may experience more severe side effects. Because sodium stibogluconate treats a parasitic infection, there is a chance that the parasite will be resistant to treatment.

Continue Learning about Anti-Infective Agent

Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.